Skip to main content

Secondary Headaches

  • Chapter
  • First Online:
Fundamentals of Pain Medicine

Abstract

A new headache occurring simultaneously with another disorder recognized as capable of causing headache is always diagnosed as secondary. Secondary headache is usually expected to improve or go away within 3 months spontaneously or after successful treatment of the cause. Finding the secondary cause is critical for treating symptomatic or sinister headaches. It is useful to differentiate secondary headaches into vascular and nonvascular secondary types. Primary headache disorders can coexist with, worsen, or transform into secondary headache disorders. Secondary headaches are less common than primary headaches in pain medicine practices. It is essential to be familiar with secondary headaches and have a game plan to pursue evaluation of etiologies. The International Classification of Headache Disorders Third Edition, beta version (ICHD-3) (Headache Classification Committee of the International Headache Society (IHS), Cephalalgia 33:629–808, 2013) that classified headache disorders should be used as a guide to categorize and diagnose secondary headaches. Medications used to treat secondary headache are generally those matched to primary headache disorders. However, many commonly used headache medicines, such as triptans or ergots, are contraindicated in secondary vascular headaches.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  1. Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorder, 3rd edition, Beta version. Cephalalgia. 2013;33:629–808.

    Article  Google Scholar 

  2. Dodick DW. Clinical clues and clinical rules: primary versus secondary headache. Adv Stud Med. 2003;3:S550–5.

    Google Scholar 

  3. Rapoport A, Stang P, Gutterman DL, Cady R, Markley H, Weeks R, et al. Analgesic rebound headache in clinical practice: data from a physician survey. Headache. 1996;36(1):14–9.

    Article  CAS  PubMed  Google Scholar 

  4. Mathew NT. Transformed migraine, analgesic rebound, and other chronic daily headaches. Neurol Clin. 1997;15(1):167–86.

    Article  CAS  PubMed  Google Scholar 

  5. Bigal ME, Sheftell FD, Rapoport AM, Tepper SJ, Lipton RB. Chronic daily headache: identification of factors associated with induction and transformation. Headache. 2002;42(7):575–81.

    Article  PubMed  Google Scholar 

  6. Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache. 2008;48(8):1157–68.

    Article  PubMed  Google Scholar 

  7. Bigal ME, Lipton RB. Concepts and mechanisms of migraine chronification. Headache. 2008;48(1):7–15.

    Article  PubMed  Google Scholar 

  8. Srikiatkhachorn A. Chronic daily headache: a scientist’s perspective. Headache. 2002;42(6):532–7.

    Article  PubMed  Google Scholar 

  9. Srikiatkhachorn A, Tarasub N, Govitrapong P. Effect of chronic analgesic exposure on the central serotonin system: a possible mechanism of analgesic abuse headache. Headache. 2000;40(5):343–50.

    Article  CAS  PubMed  Google Scholar 

  10. Srikiatkhachorn A, le Grand SM, Supornsilpchai W, Storer RJ. Pathophysiology of medication overuse headache-an update. Headache. 2014;54(1):204–10.

    Article  PubMed  Google Scholar 

  11. Moskowitz MA. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol Sci. 1992;13(8):307–11.

    Article  CAS  PubMed  Google Scholar 

  12. De Felice M, Porreca F. Opiate-induced persistent pronociceptive trigeminal neural adaptations: potential relevance to opiate-induced medication overuse headache. Cephalalgia. 2009;29(12):1277–84.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Katsarava Z, Schneeweiss S, Kurth T, et al. Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology. 2004;62:788–90.

    Article  CAS  PubMed  Google Scholar 

  14. Mokri B. Low cerebrospinal fluid pressure syndromes. Neurol Clin. 2004;22(1):55–74. vi.

    Article  PubMed  Google Scholar 

  15. Schievink WI. Spontaneous spinal cerebrospinal fluid leaks. Cephalalgia. 2008;28(12):1345–56.

    Article  CAS  PubMed  Google Scholar 

  16. Forsyth PA, Posner JB. Headaches in patients with brain tumors: a study of 111 patients. Neurology. 1993;43(9):1678–83.

    Article  CAS  PubMed  Google Scholar 

  17. Weyand CM, Goronzy JJ. Giant-cell arteritis and polymyalgia rheumatica. Ann Intern Med. 2003;139(6):505–15.

    Article  PubMed  Google Scholar 

  18. Calabrese LH, Dodick DW, Schwedt TJ, Singhal AB. Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med. 2007;146(1):34–44.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Brinder Vij MD, FACP, FAHS .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Vij, B., Tepper, S.J. (2018). Secondary Headaches. In: Cheng, J., Rosenquist, R. (eds) Fundamentals of Pain Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-64922-1_32

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-64922-1_32

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-64920-7

  • Online ISBN: 978-3-319-64922-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics